NDC properties for "Eliquis 30-Day Starter Pack" (RxCUI 1992428)
About this data
The tables show NDC propoerties for Eliquis 30-Day Starter Pack with the RxCUI 1992428
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Eliquis 30-Day Starter Pack (RxCUI 1992428)
| MMSL_CODE | BD28047 |
|---|---|
| NDA | NDA202155 |
| RxCUI | 1992428 |
| SPL_SET_ID | e9481622-7cc6-418a-acb6-c5450daae9b0 |
| Prescribable Synonym | Eliquis 30-Day Starter Pack |
| RXNAV_STR | Eliquis 30-Day Starter Pack |
| RxNorm Name | {74 (apixaban 5 MG Oral Tablet [Eliquis]) } Pack [Eliquis 30-Day Starter Pack] |
| RxNorm Synonym | Eliquis 30-Day Starter Pack |
| Related queries | Interactions (for RxCUI 1992428) |
NDC Properties
NDC Item 00003376432
| NDC 9 | 0003-3764 |
|---|---|
| NDC 10 | 0003-3764-32 |
| NDC Item | 00003376432 |
| FDA SPL set id | 690559 |
| Labeler | E.R. Squibb & Sons, L.L.C. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-11-29 |
| Marketing status | ACTIVE |
| NDA | NDA202155 |
| Related queries | Properties for NDC 9 0003-3764 |
NDC Item 00003376442
| NDC 9 | 0003-3764 |
|---|---|
| NDC 10 | 0003-3764-42 |
| NDC Item | 00003376442 |
| FDA SPL set id | 690559 |
| Labeler | E.R. Squibb & Sons, L.L.C. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-11-29 |
| Marketing status | ACTIVE |
| NDA | NDA202155 |
| Related queries | Properties for NDC 9 0003-3764 |
NDC Item 00003376474
| NDC 9 | 0003-3764 |
|---|---|
| NDC 10 | 0003-3764-74 |
| NDC Item | 00003376474 |
| Packaging | 1 KIT in 1 CARTON (0003-3764-74) * 32 TABLET, COATED in 1 BLISTER PACK * 42 TABLET, COATED in 1 BLISTER PACK |
| FDA SPL set id | 690559 |
| Labeler | E.R. Squibb & Sons, L.L.C. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-11-29 |
| Marketing status | ACTIVE |
| NDA | NDA202155 |
| Related queries | Properties for NDC 9 0003-3764 |
NDC Item 00003376432
| NDC 9 | 0003-3764 |
|---|---|
| NDC 10 | 0003-3764-32 |
| NDC Item | 00003376432 |
| FDA SPL set id | 690559 |
| Labeler | E.R. Squibb & Sons, L.L.C. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-11-29 |
| Marketing status | ACTIVE |
| NDA | NDA202155 |
| Related queries | Properties for NDC 9 0003-3764 |
NDC Item 00003376442
| NDC 9 | 0003-3764 |
|---|---|
| NDC 10 | 0003-3764-42 |
| NDC Item | 00003376442 |
| FDA SPL set id | 690559 |
| Labeler | E.R. Squibb & Sons, L.L.C. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-11-29 |
| Marketing status | ACTIVE |
| NDA | NDA202155 |
| Related queries | Properties for NDC 9 0003-3764 |
NDC Item 00003376474
| NDC 9 | 0003-3764 |
|---|---|
| NDC 10 | 0003-3764-74 |
| NDC Item | 00003376474 |
| Packaging | 1 KIT in 1 CARTON (0003-3764-74) * 32 TABLET, COATED in 1 BLISTER PACK * 42 TABLET, COATED in 1 BLISTER PACK |
| FDA SPL set id | 690559 |
| Labeler | E.R. Squibb & Sons, L.L.C. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-11-29 |
| Marketing status | ACTIVE |
| NDA | NDA202155 |
| Related queries | Properties for NDC 9 0003-3764 |
NDC Item 00003376432
| NDC 9 | 0003-3764 |
|---|---|
| NDC 10 | 0003-3764-32 |
| NDC Item | 00003376432 |
| FDA SPL set id | 690559 |
| Labeler | E.R. Squibb & Sons, L.L.C. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-11-29 |
| Marketing status | ACTIVE |
| NDA | NDA202155 |
| Related queries | Properties for NDC 9 0003-3764 |
NDC Item 00003376442
| NDC 9 | 0003-3764 |
|---|---|
| NDC 10 | 0003-3764-42 |
| NDC Item | 00003376442 |
| FDA SPL set id | 690559 |
| Labeler | E.R. Squibb & Sons, L.L.C. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-11-29 |
| Marketing status | ACTIVE |
| NDA | NDA202155 |
| Related queries | Properties for NDC 9 0003-3764 |
NDC Item 00003376474
| NDC 9 | 0003-3764 |
|---|---|
| NDC 10 | 0003-3764-74 |
| NDC Item | 00003376474 |
| Packaging | 1 KIT in 1 CARTON (0003-3764-74) * 32 TABLET, COATED in 1 BLISTER PACK * 42 TABLET, COATED in 1 BLISTER PACK |
| FDA SPL set id | 690559 |
| Labeler | E.R. Squibb & Sons, L.L.C. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-11-29 |
| Marketing status | ACTIVE |
| NDA | NDA202155 |
| Related queries | Properties for NDC 9 0003-3764 |